Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Cymabay Therapeutics (CBAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2013	09-2013	06-2013	03-2013	12-2012
Assets
Current Assets
Cash & Cash Equivalents	24,401	32,080	N/A	N/A	N/A
Marketable Securities	6,843	N/A	N/A	N/A	N/A
Receivables	178	N/A	N/A	N/A	N/A
Other current assets	453	0	0	0	0
TOTAL	$32,239	$32,113	$N/A	$N/A	$N/A

Non-Current Assets
PPE Net	3	9	N/A	N/A	N/A
Other Non-Current Assets	258	42	0	0	0
TOTAL	$261	$51	$N/A	$N/A	$N/A

Total Assets	$32,500	$32,164	$N/A	$N/A	$N/A

Liabilities
Current Liabilities
Short Term Debt	38	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	733	1,039	0	0	0
Accrued Expenses	2,251	1,204	N/A	N/A	N/A
Other current liabilities	6,466	N/A	N/A	N/A	N/A
TOTAL	$9,488	$2,243	$N/A	$N/A	$N/A

Non-Current Liabilities
Long Term Debt	4,407	5,310	N/A	N/A	N/A
Other Non-Current Liabilities	9	4,374	0	0	0
TOTAL	$4,416	$9,815	$N/A	$N/A	$N/A

Total Liabilities	$13,904	$12,058	$N/A	$N/A	$N/A

Shareholders' Equity
Shares Outstanding, K	10,065	9,455	N/A	N/A	N/A
Common Shares	1	1	N/A	N/A	N/A
Retained earnings	-348,842	-344,928	N/A	N/A	N/A
Other shareholders' equity	2	0	0	0	0
TOTAL	$18,596	$20,106	$N/A	$N/A	$N/A

Total Liabilities And Equity	$32,500	$32,164	$0	$0	$0